# A Real-world Study to Evaluate the Primary Patency and Freedom From TLR of Endovascular Treatment in TOSAKA III In-stent Restenosis of Lower Extremity Femoropopliteal Artery.

> **NCT04801004** · — · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 322 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04801004
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 322 (ACTUAL)
- **Last updated:** 2026-03-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04801004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04801004, "A Real-world Study to Evaluate the Primary Patency and Freedom From TLR of Endovascular Treatment in TOSAKA III In-stent Restenosis of Lower Extremity Femoropopliteal Artery.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04801004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*